Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Top Story
Point-of-Care Testing
POC test offers low-cost way to screen for toxoplasmosis during pregnancy
Gestational screening programs might benefit from a new clinical laboratory point-of-care (POC) diagnostic test that hunts for a parasite that can be transmitted during pregnancy.
Featured
FDA Submission
Guardant's CRC screening test receives advisory committee recommendation
FDA Clearance
BioMérieux TBI test receives FDA 510(k) clearance
Latest News
Cue Health files for Chapter 7 bankruptcy
May 30, 2024
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Molecular testing studied for remote post-transplant care
May 21, 2024
New approach may improve CRISPR safety, accuracy
May 21, 2024
Business Insights
FDA Submission
Guardant's CRC screening test receives advisory committee recommendation
FDA Clearance
BioMérieux TBI test receives FDA 510(k) clearance
Diagnostic Technologies
Roche extends partnership, will offload Genentech
Trends and Finance
Cue Health files for Chapter 7 bankruptcy
Diagnostic Technologies
Sequencing
SPT Labtech, Watchmaker Genomics collaborate on NGS library prep automation
Research and Development
Novel oncology tests capture large share of new PLA codes effective July 1
Lawsuit
U.K. Patents Court orders Advanced Cell Diagnostics to pay Molecular Instruments, revokes patents
Molecular Diagnostics
Molecular testing studied for remote post-transplant care
Diseases
FDA Submission
Guardant's CRC screening test receives advisory committee recommendation
FDA Clearance
BioMérieux TBI test receives FDA 510(k) clearance
Research Grant
GMU researchers receive $1.2M in funding for Lyme disease urine test
Trends and Finance
Cue Health to cease operations, lay off all employees
More from LabPulse.com
Roche extends partnership, will offload Genentech
By
LabPulse.com staff writers
Japan-based Hitachi High-Tech and Switzerland-based Roche have extended their IVD development support partnership for another 10 years, the companies announced.
May 30, 2024
SPT Labtech, Watchmaker Genomics collaborate on NGS library prep automation
By
LabPulse.com staff writers
SPT Labtech and Watchmaker Genomics are collaborating on automated next-generation sequencing (NGS) library preparation, integrating Watchmaker's sample prep assay kits with SPT Labtech's all-in-one liquid handling Firefly platform.
May 28, 2024
GMU researchers receive $1.2M in funding for Lyme disease urine test
By
LabPulse.com staff writers
Researchers at George Mason University (GMU) have received $1.2 million in federal funding from the U.S. Department of the Army to develop a urine-based test for the detection and diagnosis of Lyme disease.
May 24, 2024
Novel oncology tests capture large share of new PLA codes effective July 1
By
LabPulse.com staff writers
Deadline for next Clinical Laboratory Fee Schedule (CLFS) annual meeting in June is May 30.
May 23, 2024
FDA green lights Indica's Halo with Hamamatsu for digital pathology
By
LabPulse.com staff writers
In the U.S., Indica Labs will continue to offer Halo AP for research use only applications but will now offer Halo AP Dx for primary diagnosis of surgical pathology slides prepared from FFPE tissue.
May 24, 2024
Nanopath awarded $4M in SBIR grants
By
LabPulse.com staff writers
Nanopath has announced that it has been awarded two grants worth a total of $4 million in federal funding through the Small Business Innovation Research (SBIR) program.
May 22, 2024
New additions to Orchard Software announced
By
LabPulse.com staff writers
Orchard Software has partnered with Pathology and Cytology Laboratories (P&C Labs) to support P&C's implementation of digital pathology alongside Orchard's enterprise pathology LIS.
May 24, 2024
U.K. Patents Court orders Advanced Cell Diagnostics to pay Molecular Instruments, revokes patents
By
LabPulse.com staff writers
The Patents Court of the High Court of England and Wales has ordered that two patents owned by Bio-Techne brand Advanced Cell Diagnostics be revoked and has dismissed ACD's infringement claims against Molecular Instruments.
May 23, 2024
Biogen bets $1.15B on HI-Bio's autoimmune kidney disease drug
By
LabPulse.com staff writers
The therapy could ultimately improve clinical outcomes in a broad range of immune-mediated diseases, according to Biogen.
May 22, 2024
Oxford Nanopore integrates Twist technology for long-read sequencing
By
LabPulse.com staff writers
The newly unveiled Twist-Oxford Nanopore long-read PGx solution is available for research use only.
May 22, 2024
Amgen gets FDA approval for small cell lung cancer therapy
By
LabPulse.com staff writers
Amgen announced on Thursday that the U.S. Food and Drug Administration (FDA) has approved its therapy tarlatamab, to be marketed under the name Imdelltra, for the treatment of extensive-stage small cell lung cancer (ES-SCLC).
May 17, 2024
Karius gets FDA breakthrough device designation for infectious disease test
By
LabPulse.com staff writers
Karius announced today that its Karius Test for the diagnosis and management of lung infections in immunocompromised patients has been granted breakthrough device designation from the FDA.
May 16, 2024